Chih-Chien Chou

AMPK Reverses the Mesenchymal Phenotype of Cancer Cells by Targeting the Akt–MDM2–Foxo3a Signaling Axis

Chih-Chien Chou, Kuen‐Haur Lee, I‐Lu Lai et al. · Cancer Research · 2014 · 171 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Antitumor effects of OSU-2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma

Hany A. Omar, Chih-Chien Chou, Lisa D. Berman-Booty et al. · Hepatology · 2011 · 75 citations

Life Sciences, Oncology, Pharmacology +17

Chalcomoracin is a potent anticancer agent acting through triggering Oxidative stress via a mitophagy- and paraptosis-dependent mechanism

Haote Han, Chih-Chien Chou, Ruyi Li et al. · Scientific Reports · 2018 · 54 citations · Full text

Life Sciences, Oncology, Pharmacology +17

A novel HIF-1α-integrin-linked kinase regulatory loop that facilitates hypoxia-induced HIF-1α expression and epithelial-mesenchymal transition in cancer cells

Chih-Chien Chou, Hsaio-Ching Chuang, Santosh B. Salunke et al. · Oncotarget · 2015 · 48 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

RETRACTED: Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells

I‐Lu Lai, Chih-Chien Chou, Po‐Ting Lai et al. · Carcinogenesis · 2014 · 37 citations · Full text

Medicine, Oncology, Pharmacology +15